scroll
LEARN MORE
Performance update for March, stocks that drove returns & our current positioning
Close
Friday 19th April – DOW up 22pts, SPI down -55pts
Close
Market Matters Research Lead Shawn Hickman with David Koch
Close
Thursday 18th April – ASX200 +32pts, Resmed (RMD), Transurban (TCL), Santos (STO) & SRG Global (SRG)
Close
14 DAYS FREE ACCESS
Join Market Matters and get full access
to all our Opinion + Action
MSB $0.78
20 MINUTE DELAYED
ANALYSIS
OPINION
ACTION
i
PERFORMANCE
i
| SHARE PRICE ACTIVITY | |
|---|---|
| Last (Price) | 0.78 |
| Change | 0.00 (0.00) |
| Bid / Ask | 0.78 - 0.73 |
| Volume | 0 |
| Turnover | 0 |
| Open | 0.00 |
| Day Range | 0.76 - 0.80 |
| VWAP | 0.00 |
| Prev Close | 0.78 |
| Last Trade | 19/04 9:20am (AEST) |
i
| KEY INFORMATION | |
|---|---|
| Sector | Healthcare |
| Shares Issued | 890,565,210 |
| NTA/Share | 0.00 |
| Last Dividend | 0.00 |
| Dividend Ex Date | 0 |
| Dividend Pay Date | 22 MAR 2006 |
i
| CURRENT () | |
|---|---|
| Revenue | |
| EBITDA | |
| Profit | |
| Earnings Per Share (EPS) | 0 |
| Dividend Per Share (DPS) | 0 |
| Yield % | 0.00 |
| Market Cap | 0 |
| Price to Earnings Ratio (P/E) | 0 |
i
TARGET PRICE FORECAST
i
| ESTIMATES () | |
|---|---|
| Revenue | 0.00 |
| EBITDA | 0.00 |
| Profit | 0.00 |
| Earnings Per Share (EPS) | 0.00 |
| Dividend Per Share (DPS) | 0.00 |
i
BROKER CONSENSUS RECOMMENDATION
BUY
SELL
Target Price
0.00
Lt Growth Rate
0.00
Recommendation ()
0.00
ACTION
MSB
UPDATED
01/07/2021 16:47
Business Summary
Mesoblast (MSB) provides biomedical services. The Company develops drugs for cardiovascular diseases, oncology, hematology, and spine orthopedic disorders treatment. Mesoblast conducts its business worldwide.
Relevant suggested news and content from the site
Video
WATCH
Performance update for March, stocks that drove returns & our current positioning
Recorded Tuesday 9th April
Podcast
LISTEN
Friday 19th April – DOW up 22pts, SPI down -55pts
Daily Podcast Direct from the Desk
Video
WATCH
Market Matters Research Lead Shawn Hickman with David Koch
Recorded Monday 25th March
Podcast
LISTEN
Thursday 18th April – ASX200 +32pts, Resmed (RMD), Transurban (TCL), Santos (STO) & SRG Global (SRG)
Daily Podcast Direct from the Desk
Only available to Members
Take a free 14 day Market Matters trial – full access to all our reports, portfolios, positions, buy and sell recommendations. Access the latest views on the latest developments from professional money managers. It's free and no payment details are required
For membership options and pricing.
Click here
